Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

BIOS

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BIOS
DataHoraFonteTítuloCódigoCompanhia
04/10/202308:30GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to LiquidateNASDAQ:BIOSBioPlus Acquisition Corporation
04/10/202308:30GlobeNewswire Inc.Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business CombinationNASDAQ:BIOSBioPlus Acquisition Corporation
16/08/202309:30GlobeNewswire Inc.Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient MonitoringNASDAQ:BIOSBioPlus Acquisition Corporation
17/07/202309:00GlobeNewswire Inc.Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of DirectorsNASDAQ:BIOSBioPlus Acquisition Corporation
14/06/202307:09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOSBioPlus Acquisition Corporation
14/06/202307:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOSBioPlus Acquisition Corporation
13/06/202309:30GlobeNewswire Inc.Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth OrlandoNASDAQ:BIOSBioPlus Acquisition Corporation
15/05/202317:29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOSBioPlus Acquisition Corporation
15/05/202307:38Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:BIOSBioPlus Acquisition Corporation
12/05/202317:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
03/05/202309:30GlobeNewswire Inc.Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition CorporationNASDAQ:BIOSBioPlus Acquisition Corporation
27/04/202317:35Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BIOSBioPlus Acquisition Corporation
14/02/202317:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOSBioPlus Acquisition Corporation
02/02/202312:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOSBioPlus Acquisition Corporation
11/03/202218:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BIOSBioPlus Acquisition Corporation
06/12/202110:00GlobeNewswire Inc.BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public OfferingNASDAQ:BIOSBioPlus Acquisition Corporation
03/02/202010:30GlobeNewswire Inc.Option Care Health Completes Reverse Stock Split and Ticker Symbol ChangeNASDAQ:BIOSBioPlus Acquisition Corporation
26/12/201918:24GlobeNewswire Inc.RLH Corporation Appoints R. Carter Pate as ChairmanNASDAQ:BIOSBioPlus Acquisition Corporation
18/12/201911:22GlobeNewswire Inc.Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
02/12/201910:00GlobeNewswire Inc.Daniel E. Greenleaf Appointed as Chief Executive Officer of The Providence Service Corporation and LogistiCareNASDAQ:BIOSBioPlus Acquisition Corporation
21/11/201912:39GlobeNewswire Inc.Option Care Health to Participate in the Bank of America Merrill Lynch 2019 Leveraged Finance ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
19/11/201916:14GlobeNewswire Inc.Option Care Health Selected by Highmark as Preferred Provider of Hemophilia TreatmentNASDAQ:BIOSBioPlus Acquisition Corporation
06/11/201908:00GlobeNewswire Inc.Option Care Health Announces Third Quarter ResultsNASDAQ:BIOSBioPlus Acquisition Corporation
16/10/201917:05GlobeNewswire Inc.Option Care Health to Announce Third Quarter 2019 Financial Results and Host Conference CallNASDAQ:BIOSBioPlus Acquisition Corporation
29/08/201919:05Business WireOption Care Health to Participate in the Morgan Stanley 17th Annual Global Healthcare ConferenceNASDAQ:BIOSBioPlus Acquisition Corporation
28/08/201918:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BIOSBioPlus Acquisition Corporation
27/08/201917:01GlobeNewswire Inc.Kathryn Stalmack appointed as SVP, General Counsel and Corporate Secretary of Providence Service Corporation and LogistiCareNASDAQ:BIOSBioPlus Acquisition Corporation
13/08/201918:00Business WireOption Care Health Receives Anticipated Nasdaq NoticeNASDAQ:BIOSBioPlus Acquisition Corporation
08/08/201918:24Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BIOSBioPlus Acquisition Corporation
07/08/201919:58Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BIOSBioPlus Acquisition Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:BIOS